A new therapeutic target for myelofibrosis is cause for Gli

Brian Jonas

doi:10.1126/scitranslmed.aan4297

A new therapeutic target for myelofibrosis is cause for Gli

Brian Jonas

Hematology and Oncology

Research output: Contribution to journal › Review article

Abstract

Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor.

Original language	English (US)
Article number	aan4297
Journal	Science Translational Medicine
Volume	9
Issue number	392
DOIs	https://doi.org/10.1126/scitranslmed.aan4297
State	Published - May 31 2017

Fingerprint

ASJC Scopus subject areas

Medicine(all)

Cite this

Jonas, B. (2017). A new therapeutic target for myelofibrosis is cause for Gli. Science Translational Medicine, 9(392), [aan4297]. https://doi.org/10.1126/scitranslmed.aan4297

@article{dfd87a25b0f4479aa01f29f9b990dec6,

title = "A new therapeutic target for myelofibrosis is cause for Gli",

abstract = "Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor.",

author = "Brian Jonas",

year = "2017",

month = may

day = "31",

doi = "10.1126/scitranslmed.aan4297",

language = "English (US)",

volume = "9",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "392",

}

TY - JOUR

T1 - A new therapeutic target for myelofibrosis is cause for Gli

AU - Jonas, Brian

PY - 2017/5/31

Y1 - 2017/5/31

N2 - Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor.

AB - Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=85020287743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020287743&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aan4297

DO - 10.1126/scitranslmed.aan4297

M3 - Review article

C2 - 28566426

AN - SCOPUS:85020287743

VL - 9

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 392

M1 - aan4297

ER -

Access to Document

10.1126/scitranslmed.aan4297